Inventor · disambiguated record
Suet C. Yeung
Also filed as: YEUNG SUET C · YEUNG SUET CHUNG
22 granted patents·8 pending applications·59 citations·filing 2015–2025
93Inventor score
Files withGILEAD SCIENCES INC30
Top patents by PatentIndex Score
30 records- 0194US11224600B2Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Jan 18, 2022·9 cites·21 claims
- 0293US11897878B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Feb 13, 2024·2 cites·65 claims
- 0392US11925631B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·2 cites·37 claims
- 0492US11897862B2IKAROS zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·2 cites·10 claims
- 0591US9499523B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Nov 22, 2016·14 cites·32 claims
- 0689US11845723B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Dec 19, 2023·3 cites·41 claims
- 0789US11179383B2Compounds for inhibition of α4β7 integrinGILEAD SCIENCES INC·Filed 2019·Granted Nov 23, 2021·3 cites·20 claims
- 0889US11071730B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jul 27, 2021·4 cites·40 claims
- 0988US11976072B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 7, 2024·1 cites·19 claims
- 1088US11203591B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2019·Granted Dec 21, 2021·6 cites·45 claims
- 1183US11174256B2Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2019·Granted Nov 16, 2021·2 cites·18 claims
- 1283US11116760B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2019·Granted Sep 14, 2021·3 cites·23 claims
- 1380US2025361236A9Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1479US9951065B2Benzimidazole and imadazopyridine carboximidamide compoundsGILEAD SCIENCES INC·Filed 2016·Granted Apr 24, 2018·3 cites·23 claims
- 1579US2025382278A1Ikaros zinc finger family degraders and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1678US12258346B2Substituted 6-azabenzimidazole compoundsGILEAD SCIENCES INC·Filed 2023·Granted Mar 25, 2025·0 cites·23 claims
- 1777US2025032473A1Quinoline derivativesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1876US10221197B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Mar 5, 2019·2 cites·13 claims
- 1975US12358887B2IKAROS Zinc Finger Family degraders and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 2075US10092563B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Oct 9, 2018·2 cites·11 claims
- 2173US2024199596A1Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2268US12053462B2Quinoline derivativesGILEAD SCIENCES INC·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 2368US11932634B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 2467US10308639B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 4, 2019·1 cites·20 claims
- 2565US2022226337A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2665US2022152014A1Compounds for inhibition of alpha 4 beta 7 integrinGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2763US2022135561A1Imidazopyridine derivativesGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 2859US11926628B2Diacylglyercol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 2948US2025353817A1Interlukin-17a inhibitors and uses thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 3040US11021467B2Phosphatidylinositol 3-kinase inhibitorsGILEAD SCIENCES INC·Filed 2015·Granted Jun 1, 2021·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →